Skip to main content
Fig. 2 | Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Fig. 2

From: suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients

Fig. 2

Cumulative incidence plot of patients’ risk of acute surgery stratified by suPAR concentrations. Competing risks are death and elective surgery. Inset: zoom on the first 30-day interval is shown. suPAR 0–3 ng/ml included 9720 (56.2%) patients, suPAR 3–6 ng/ml included 5537 (32.0%) patients, suPAR 6–9 ng/ml included 1299 (7.5%) patients, and suPAR >9 ng/ml included 756 (4.4%) patients. Log-rank test showed p < 0.0001. suPAR, soluble urokinase plasminogen activator receptor

Back to article page